Commercial Prior Authorization / Notification List (partial)
Customize your policy alerts
Sign up for all Baylor Scott & White Health Plan policy alerts
Know when Baylor Scott & White Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
Lists CPT/procedure codes requiring prior authorization or notification for BSWHP commercial products; explains portal submission and benefit verification requirements; affects network providers submitting authorization requests for commercial members.
No material clinical or coverage changes in this revision.
Coverage determinations and code inclusions
Coverage determination notes (partial)
Coverage and authorization stance (partial):
Codes requiring prior authorization/notification (partial)
This segment enumerates specific CPT procedure codes that require the payer's prior authorization or notification as part of the commercial PA/notification list.
Prior authorization/notification code list (partial)
This partial list identifies CPT codes that are subject to the payer's prior authorization or notification requirements; each code entry includes an associated effective date.
Code list (excerpt)
This excerpt enumerates procedure codes subject to prior authorization/notification; no specific clinical coverage criteria are provided in these chunks.
Coverage stance for listed CPT codes
The excerpt lists CPT codes subject to prior authorization or notification and often includes associated dates; no detailed clinical criteria are present in this segment.
Listed CPT codes requiring prior authorization/notification
This excerpt enumerates CPT codes and, where present, associated effective/mapping dates which indicate inclusion on the payer's prior authorization/notification list.
Prior authorization/notification inclusion (partial)
This excerpt enumerates CPT codes that are included on the commercial prior authorization/notification list; inclusion implies these services require prior authorization or notification per payer policy.
Coverage criteria and panel content requirements
For many molecular pathology panels, the list specifies required minimum gene content or scope for the panel to be recognized on the list.
ALL of the following
- Aortic dysfunction/dilation panels must include sequencing of at least 9 genes, including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK.
- Hearing loss genomic panels must include sequencing of at least 60 genes (examples include CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A, WFS1).
- Drug metabolism/pharmacogenomics genomic panels must include testing of at least 6 genes including CYP2C19 and CYP2D6 and must include CYP2D6 duplication/deletion analysis.
Coverage entries in this segment
This extract lists CPT codes with associated test/panel descriptions and any specified panel size or analysis requirements; it indicates which services are included in the prior authorization/notification list.
Code listing and reference — no clinical criteria in this segment
This portion of the policy provides code-level entries and brief descriptions; specific coverage determinations, criteria, or prior authorization requirements are referenced by code and effective date but detailed clinical criteria are not present in this segment.
Codes requiring prior authorization/notification (partial list)
This section is a code list used to indicate services that require prior authorization or notification per the commercial prior authorization/notification policy.
Listed services subject to authorization/notification (partial list)
The document window enumerates services and tests that are subject to prior authorization/notification and provides effective dates; clinical applicability and criteria are implied by the service descriptions (eg, oncology MRD assays, genomic panels, infectious agent ddPCR).
Listings without embedded coverage criteria (partial)
This partial section enumerates specific procedure and laboratory test codes and brief descriptions; it does not include explicit coverage criteria text in these chunks.
Prior authorization/notification code list (partial)
This section enumerates codes that require prior authorization or notification for commercial members; specific coverage criteria are maintained elsewhere in the policy set.
Code listing continuation — no standalone criteria in this excerpt
Continuation of code and descriptor listings (no explicit coverage rules or criteria in this segment).
CPT, HCPCS, and proprietary codes (grouped)
| 00170 | Anesthesia for intraoral procedures, including biopsy; not otherwise specified. |
| 11950 | Subcutaneous injection of filling material (eg, collagen); 1 cc or less. |
| 11951 | Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc. |
| 11952 | Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc. |
| 11954 | Subcutaneous injection of filling material (eg, collagen); over 10.0 cc. |
| 14041 | Adjacent tissue transfer or rearrangement; defect 10.1 sq cm to 30.0 sq cm. |
| 14301 | Adjacent tissue transfer; defect 30.1 sq cm to 60.0 sq cm. |
| 15100 | Split-thickness autograft, trunk, arms, legs; first 100 sq cm or less. |
| 15200 | Full thickness graft, free, including direct closure of donor site, trunk; 20 sq cm or less. |
| 15771 | Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate. |
| 22515 | Percutaneous vertebral augmentation (kyphoplasty), 1 vertebral body |
| 22526 | Percutaneous intradiscal electrothermal annuloplasty; single level |
| 22527 | Percutaneous intradiscal electrothermal annuloplasty; additional levels |
| 22532 | Arthrodesis, lateral extracavitary technique; thoracic |
| 22533 | Arthrodesis, lateral extracavitary technique; lumbar |
| 27125 | Hemiarthroplasty, hip, partial (mapped in list) |
| 27130 | Total hip arthroplasty (mapped in list) |
| 27486 | Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (total knee arthroplasty) |
| 27438 | Arthroplasty, patella; with prosthesis |
| 29805 | Arthroscopy, shoulder, diagnostic |
| 29827 | Arthroscopy, shoulder, with rotator cuff repair |
| 29867 | Arthroscopy, knee, surgical; osteochondral allograft (eg, mosaicplasty) |
| 29868 | Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (total knee arthroplasty) / meniscal transplantation |
| 29870 | Arthroscopy, knee, diagnostic, with or without synovial biopsy |
| 29871 | Arthroscopy, knee, surgical; for infection, lavage and drainage |
| 38240 | Transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer = Hematopoietic progenitor cell (HPC); allogeneic transplantation per donor. |
| 38241 | Transplant preparation of hematopoietic progenitor cells; ... = Hematopoietic progenitor cell (HPC); autologous transplantation. |
| 40799 | Unlisted procedure, lips (mapped here to transplant prep entry in list). |
| 63003 | Laminectomy/related spinal decompression procedures (various segments/regions) as listed |
| 63005 | Laminectomy with exploration and/or decompression, lumbar, 1-2 segments |
| 63012 | Laminectomy with removal of abnormal facets/pars for spondylolisthesis, lumbar (Gill type) |
| 63015 | Laminectomy, cervical, more than 2 segments |
| 63017 | Laminectomy, lumbar, more than 2 segments |
| 63020 | Laminotomy with decompression, cervical (1 interspace) |
| 63030 | Laminotomy with decompression, lumbar (1 interspace) |
| 63035 | Each additional interspace cervical or lumbar (add-on) |
| 63650 | Percutaneous implantation of neurostimulator electrode array, epidural |
| 63655 | Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural |
| 63685 | Insertion/replacement of spinal neurostimulator pulse generator |
| 64590 | Insertion/replacement of peripheral/sacral/gastric neurostimulator pulse generator |
| 64454 | Genicular nerve branch injection(s) with imaging guidance |
| 64479 | Transforaminal epidural injection, cervical/thoracic, single level with imaging guidance |
| 64484 | Transforaminal epidural injection, lumbar/sacral, single level |
| 64510 | Injection; stellate ganglion (cervical sympathetic) |
| 64628 | Thermal destruction of intraosseous basivertebral nerve (first 2 vertebral bodies) |
| 64629 | Thermal destruction of intraosseous basivertebral nerve each additional vertebral body |
| 70543-70555 | Magnetic resonance angiography and MRI brain/neck/head related CPT codes listed in excerpt |
| 71250-71275 | CT thorax and CTA chest codes referenced |
| 72125-72159 | CT/MR spine and related codes |
| 73200-73225 | CT/MR upper extremity and angiography codes |
| 73700-73725 | CT/MR lower extremity and angiography codes |
| 74150-74185 | CT/MR abdomen and pelvis codes |
| 75557-75577 | Cardiac MRI/CT and related codes |
| 76376-76391 | 3D rendering and MR spectroscopy/elastography codes |
| 77262-77370 | Therapeutic radiology treatment planning and related codes |
| 77306 | Therapeutic radiology treatment planning; simple (teletherapy isodose plan) |
| 77307 | Therapeutic radiology treatment planning; complex (teletherapy isodose plan; multiple areas or special beam considerations) |
| 77316 | Therapeutic radiology treatment planning; brachytherapy isodose plan; simple |
| 77317 | Therapeutic radiology treatment planning; brachytherapy isodose plan; intermediate |
| 77318 | Therapeutic radiology treatment planning; brachytherapy isodose plan; complex |
| 77321 | Special teletherapy port plan, particles, hemibody, total body |
| 77331 | Special dosimetry (e.g., TLD, microdosimetry) when prescribed |
| 77332 | Treatment devices, design and construction; simple |
| 77333 | Treatment devices, intermediate |
| 77334 | Treatment devices, complex |
| 77336 | Continuing medical physics consultation, reported per week |
| 77338 | Multi-leaf collimator device(s) for IMRT |
| 77372 | Radiation treatment delivery, stereotactic radiosurgery (SRS), 1 session |
| 77402 | Radiation treatment delivery; Level 1 including imaging guidance when performed |
| 77407 | Radiation treatment delivery; Level 2, single-isocenter photons including imaging guidance |
| 77412 | Radiation treatment delivery; Level 3, multiple isocenters or single-isocenter with active motion management |
| 77600 | Hyperthermia, externally generated; superficial |
| 77605 | Hyperthermia, externally generated; deep |
| 77750 | Infusion or instillation of radioelement solution |
| 77761 | Intracavitary radiation source application; simple |
| 77762 | Intracavitary radiation source application; intermediate |
| 77763 | Intracavitary radiation source application; complex |
| 77767 | Remote afterloading HDR radionuclide skin surface brachytherapy; lesion up to 2.0 cm or 1 channel |
| 78012 | Thyroid uptake quantitative measurement(s) |
| 78013 | Thyroid imaging |
| 78103 | Bone marrow imaging; multiple areas |
| 78300 | Bone and/or joint imaging; limited area |
| 78430 | Myocardial imaging, PET perfusion study; single study with CT transmission scan |
| 78451 | Myocardial perfusion imaging, tomographic (SPECT); single study |
| 78494 | Myocardial PET perfusion multiple studies = cardiac blood pool imaging, gated equilibrium, SPECT |
| 78605-78660, 78699 | Myocardial imaging PET perfusion and related nuclear medicine procedures mapped to various brain, CSF, vascular flow, and other imaging procedure descriptions in list excerpt. |
| 78700-78730, 78761 | Kidney and urinary tract nuclear medicine studies and related mappings (morphology, function, residual, reflux, testicular imaging). |
| 78800-78832, 78831-78832 | Radiopharmaceutical localization and PET imaging codes with planar, tomographic, whole body, and SPECT descriptions. |
| 81161-81167, 81175, 81194 | Genetic test codes (BRCA, dystrophin, ASXL1, NTRK) listed with effective dates. |
| 81201-81226 | Gene-specific analyses (APC, BRAF, BRCA variants, CFTR, CYP2C19, CYP2D6, etc.) with dates. |
| 81301-81351 | Genomic/cytogenomic and related analyses (microsatellite instability, MECP2, PALB2, SLCO1B1, SMN1, TP53, etc.) with dates. |
| 81408-81443 | Molecular pathology procedure levels and multi-gene panel descriptions (exome, genome, condition-specific panels) with required gene lists and dates. |
| 81430 | Molecular pathology procedure (single gene/exon-level analyses) referenced for hearing loss genes |
| 81431 | Molecular pathology Level 8; genomic panels for hearing loss including duplication/deletion and copy number analyses |
| 81439 | Molecular pathology Level 8; hereditary cardiomyopathy panels, sequencing of at least 5 cardiomyopathy-related genes |
| 81442 | Molecular pathology Level 8; Noonan spectrum disorder panels, sequencing of at least 12 specified genes |
| 81503 | mRNA gene expression profiling (ex: coronary artery disease mapping to oncology ovarian assay described) |
| 81519 | mRNA gene expression profiling for oncology (breast) — 21-gene recurrence score referenced |
| 81541 | mRNA gene expression profiling for prostate, 46 genes, disease-specific mortality risk score |
| 0001U | Red blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups |
| 0003U | Oncology (ovarian) biochemical assays of five proteins, algorithm reported as a likelihood score |
| 0005U | Oncology (prostate) gene expression profile by RT-PCR of 3 genes, urine, algorithm reported as risk score |
| 0122U | Infectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance gene (example mapping in list). |
| 0130U | Targeted mRNA sequence analysis panel (hereditary colon cancer disorders) (List separately). |
| 0140U | Fungal pathogen identification, DNA (15 fungal targets), blood culture, amplified probe technique. |
| 0152U | Microbial cell-free DNA, plasma, untargeted next-generation sequencing. |
| 0211U | Oncology pan-tumor DNA and RNA by next-generation sequencing, interpretative report with therapy association. |
| 0244U | Oncology comprehensive genomic profiling, 257 genes, FFPE tumor tissue. |
| 0279U | Von Willebrand factor and collagen III binding by ELISA, plasma. |
| 0350T | Radiostereometric analysis (RSA); lower extremity(ies) including hip, proximal femur, knee, and ankle when performed |
| 0355U | APOL1 risk variants (G1, G2) |
| 0395T | High dose rate electronic brachytherapy, interstitial or intracavitary treatment, per fraction |
| 0478U | Digital PCR analysis of 9 genes in FFPE tissue for actionable variants (NSCLC panel) |
| 0473T | Device evaluation and interrogation of intraocular retinal electrode array; includes reprogramming and visual training |
| 0473U | Oncology NGS of DNA (648 genes) from FFPE with matched normal, reports variants, CNVs, rearrangements, MSI, and TMB |
| 0474T | Insertion of anterior segment aqueous drainage device into supraciliary space |
| 0474U | Hereditary pan-cancer genomic panel (88 genes) germline sequencing |
| 0588T | Posterior tibial nerve electronic analysis/simple programming of implanted neurostimulation system |
| 0589T | Electronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction |
| 0590T | Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction, posterior tibial nerve, 4+ parameters |
| 0591T | Health and well-being coaching face-to-face; individual, initial assessment |
| 0592T | Health and well-being coaching face-to-face; individual, follow-up session, >=30 minutes |
| 0593T | Health and well-being coaching face-to-face; group, >=30 minutes |
| 0594T | Osteotomy, humerus, with insertion of externally controlled intramedullary lengthening device |
| 0596T | Temporary female intraurethral valve-pump; initial insertion |
| 0597T | Temporary female intraurethral valve-pump; replacement |
| 0598T | Real-time fluorescence wound imaging; first anatomic site |
What providers must do: submission, notification, and authorization
Obtain prior authorization and submit via portal
Prior Authorization is required for services listed on the Commercial Prior Authorization/Notification List. Submit requests via the secure provider portal (registered users can log in to submit an electronic preauthorization request). For help, call the number on the member's ID card or contact your Provider Relations Representative. Note: prior authorization is not a guarantee of payment; verify member benefits, eligibility, and plan limits.
- Prior authorization required for listed services.
- Submit via secure provider portal; phone number on member ID card for assistance.
- Prior authorization does not guarantee payment; verify benefits and eligibility.
Provide notification for requested services
For certain services the plan requests notification (notification-only) to assist with discharge planning, care coordination, and case management; providers should notify the plan per payer procedures.
- Notification is requested (notification-only) for certain services to support discharge planning, care coordination, and case management.
- Refer to payer procedures for how to provide notifications.
Check list for CPT codes requiring prior authorization/notification
The list includes many CPT procedure codes that require prior authorization or notification; examples shown include spine codes 22515, 22526, 22527, 22532, 22533. Providers must check the full list and obtain prior authorization where indicated.
Secure prior authorization for knee/hip arthroscopy codes
Additional knee and hip arthroscopy codes (eg, 29874–29889 and 29914–29916) appear on the list with effective dates; providers must secure prior authorization when these codes apply.
- Included arthroscopy codes: 29874–29889 (knee) and 29914–29916 (hip).
- Effective dates are shown inline on the list; consult the list for date-specific mappings.
Prior authorization for thoracic, transplant and related cardiac procedures
Various thoracic, bronchial, lung transplant and cardiac procedure codes are included on the list (examples include bronchial procedures and transplant-related codes); providers must obtain prior authorization per the code entries and effective dates.
- Examples of included codes relate to bronchoscopy with bronchial thermoplasty and lung transplant mappings.
- Refer to the list for specific cardiac and transplant procedure codes and their effective dates.
Prior authorization for cardiac, transplant, and VAD procedures
Cardiac procedures and ventricular assist device (VAD) related codes (examples listed in the document) require prior authorization or notification as indicated on the list; verify the exact code and effective date before submission.
- Cardiac/transplant/VAD procedure codes are listed with effective dates (see list entries).
- Verify the specific CPT and effective date on the Commercial PA/Notification List before requesting authorization.
Obtain prior authorization for venous and vascular procedures
Venous and vascular procedures (including sclerotherapy and endovenous ablation) such as 36465, 36466, 36473, 36474, 36475, 36478, 36483, 36836, 36837, 37700 and related codes are listed; obtain prior authorization per the list.
Prior authorization for transplant, HPC and bariatric/gastric procedures
Transplant preparation and hematopoietic progenitor cell (HPC) codes (examples: 38206–38214, 38240–38241) and bariatric/gastric procedure codes (eg, 43210, 43290–43291, 43644–43648, 43770–43773) are included on the list; prior authorization must be obtained when these services are provided.
- HPC/transplant codes listed include 38206–38214 and 38240–38241.
- Bariatric/gastric procedure codes listed include 43210, 43290–43291, 43644–43648, 43770–43773.
- Obtain prior authorization per the Commercial PA/Notification List for these transplant and bariatric services.
Reference the PA/notification code list when requesting authorization
The PA/notification list contains numerous CPT, category III (T), and proprietary (U) codes used for prior authorization/notification processing; providers must reference the list when submitting requests.
- The list enumerates CPT and unlisted procedure codes that are part of the commercial prior authorization/notification list.
- Providers must reference the list for correct codes and any mapping or effective dates when submitting authorizations.
Use exact code and effective date when requesting authorization
The document excerpt lists CPT procedure codes that require prior authorization or notification and often shows an associated effective or mapping date; providers should use the listed code and date when submitting authorization requests.
- Many code entries include an effective/mapping date shown inline (eg, 10/1/2018, 1/2/2020, 4/1/2020, 10/1/2021).
- Use the exact code and associated date from the list when initiating a prior authorization or notification.
Prior authorization for therapeutic radiology planning and devices
Therapeutic radiology planning and device codes (examples: 77306, 77307, 77316–77318, 77321, 77331–77332) are included on the list; prior authorization is required for listed treatment planning and device design services.
Prior authorization for radiation treatment delivery and management
Radiation treatment delivery and management CPTs (examples: 77372–77373, 77402, 77407, 77412, 77425–77435 and treatment management codes) are included; prior authorization is required for these radiation delivery and management services per the list.
Prior authorization for nuclear medicine and PET/SPECT studies
Extensive nuclear medicine and PET/SPECT codes (eg, 78012–78020, 78103–78104, 78430–78432, 78451–78452, 78605–78610, 78630) are included on the list; prior authorization or notification is required for these studies per the list.
- Nuclear medicine/myocardial PET and SPECT codes listed include 78430–78432, 78451–78452 and multiple 780xx/781xx/786xx codes.
- Check the list for the specific nuclear medicine CPT and associated effective date when submitting authorization.
Verify prior authorization for nuclear medicine/radiopharmaceutical codes
Numerous nuclear medicine codes across 786xx–788xx ranges and related radiopharmaceutical procedures are on the authorization/notification list; providers must obtain prior authorization or provide notification as specified.
- Nuclear medicine/radiopharmaceutical code ranges on the list include 78605–78660, 78700–78730, 78800–78832.
- Refer to the list for the exact CPT and effective/mapping date when requesting authorization.
Prior authorization for molecular pathology and genetic tests
Molecular pathology and genetic testing CPTs (811xx, 812xx, 813xx, 814xx series) are included on the PA/notification list; providers must request prior authorization or notification for listed genetic tests and observe any test-specific requirements.
- Genetic test codes listed include BRCA analyses (81162–81167, etc.) and molecular pathology procedure levels (81408–81412 and others).
- Obtain prior authorization per the list and note any effective dates for specific genetic tests.
Ensure genomic panels meet listed gene-content requirements before authorization
Genomic panels and molecular pathology entries specify minimum gene content or analysis requirements for certain panels (examples: aortic dysfunction panels must include sequencing of at least 9 named genes; hearing loss panels require copy number analyses for STRC and DFNB1/GJB2/GJB6; XLID panels must include at least 60 genes). Ensure ordered panels meet the listed panel content requirements when seeking authorization.
Confirm panel size, analytes, and sample type for expanded genomic panels
Expanded genomic sequence analysis panels and related molecular pathology CPTs (eg, 81455–81464 and others) appear on the list with gene-count thresholds and specimen-type notes (including cell-free/plasma); confirm panel size, analytes (DNA/RNA), and sample type when submitting prior authorization.
- Examples include 81456 (solid organ neoplasm panels ≥51 genes), 81462–81464 (cell-free/plasma panels with various analytes).
- Confirm DNA vs combined DNA/RNA testing and cell-free/plasma sample applicability per the list before requesting authorization.
Prior authorization for gene expression and assay-based tests
Gene expression and algorithmic/assay-based tests (examples: 81503, 81504, 81518, 81519, 81520, 81521, 81522, 81523, 81525, 81529, 81535, 81541, 81560, 81595) are listed; these often report algorithmic risk scores or categorical results and require prior authorization per the list.
Verify authorization/notification for laboratory, reproductive and immunology codes
Assorted laboratory, reproductive, immunology, vaccine and related CPTs (eg, 82523, 84999, 86015, 86036, 86037, 88267, 89250–89264, 90378–90381) are listed for notification or authorization; follow the list and effective dates when submitting.
- Examples include reproductive medicine and cryopreservation codes (89250–89264) and immunology/vaccine codes (90378–90381).
- Use the Commercial PA/Notification List to determine whether prior authorization or notification is required for these lab/reproductive codes.
Obtain authorization for imaging, ophthalmology, vestibular and cardiac codes
Imaging, ophthalmology, vestibular, and numerous cardiac catheterization CPTs (examples: 91110–91113 capsule endoscopy, 92065 orthoptic training, 92549 CDP-SOT, 93451–93461 cardiac catheterization codes) are included on the list; obtain prior authorization or provide notification as indicated.
Prior authorization for interventional, neurophysiology, psychological, and home health services
Interventional cardiology, neurophysiology, neurodiagnostic, psychological testing, and home health supervision CPTs (examples: 93590–93597, 95905, 95940–95941, 96130–96131, 99374) are on the list; prior authorization or notification is required per the list entries and effective dates.
Use the official PA/Notification list as the authorization reference
Providers must reference the Commercial Prior Authorization/Notification List when seeking prior authorization or providing notification; the list contains code descriptions and effective/mapping dates used by the plan for authorization decisions.
- Segment lists codes and descriptions that are part of the commercial PA/Notification List; providers must reference these.
- The full, current list and submission instructions are available on the Baylor Scott & White Health Plan Service Portal.
Confirm authorization requirements for U/T proprietary and temporary codes
The document includes many U- and T- proprietary codes and temporary tracking codes (eg, 0122U, 0350T, 0473U, 0474U, 0355U, 0395U, 0473T) used to identify molecular/genomic tests and emerging technologies; check the list for exact U/T code entries and effective dates before submitting authorization requests.
Include test/panel details and gene-count requirements in authorization requests
When requesting authorization for molecular/genomic tests and procedural T-codes, include test details (panel name, gene count, specimen type) and reference any gene-content or panel-size requirements noted in the list to facilitate review.
- Provide panel name, gene count, and specimen type (eg, FFPE tissue or plasma cell-free) when submitting authorization for genomic panels.
- Reference the list's gene-content requirements (eg, minimum gene counts for specific panels) in the request.
Demonstrate panels meet minimum gene-content thresholds
Some listed molecular/genomic tests specify minimum gene-content thresholds (examples: 81439 requires sequencing of at least 5 cardiomyopathy-related genes; 81442 requires at least 12 genes for Noonan spectrum panels; 81470 requires sequencing of at least 60 genes for XLID). Ensure authorization requests demonstrate the panel meets these minimums.
- 81439 (hereditary cardiomyopathy) must include sequencing of at least 5 genes (eg, DSG2, MYBPC3, MYH7, PKP2, TTN).
- 81442 (Noonan spectrum) must include sequencing of at least 12 genes (eg, BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, SOS1).
- 81470 (XLID) must include sequencing of at least 60 specified genes.
Include exact CPT and effective date for radiation/nuclear medicine authorization
For radiation and nuclear medicine services listed, use the exact CPT and effective date from the list (e.g., therapeutic radiology planning codes 77306, 77307, and radiation delivery codes 77402, 77407, 77412 show effective date 10/1/2021) when submitting prior authorization to avoid processing delays.
Verify member eligibility and benefits before services
Claims will be reviewed to determine member eligibility at time of service and benefit availability; prior authorization does not guarantee payment—providers must verify member benefits and eligibility before providing services.
- Prior authorization is not a guarantee of payment; reimbursement depends on eligibility, benefit limits and exclusions.
- Verify benefits via the member benefit booklet or customer service before providing services.
Confirm authorization for newly published or emerging codes
Newly published or assigned codes and emerging therapy services not listed may still require prior authorization; check with Baylor Scott & White Health Plan before providing these services.
- New or emerging codes/services may require prior authorization even if not yet listed.
- Contact Baylor Scott & White Health Plan to confirm authorization requirements for new codes/technologies.
Key terms and definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.